Skip to the page

Data / Form D filings / SimBioSys, Inc.

SimBioSys, Inc.: Form D filings

SimBioSys, Inc., a biotechnology company in Chicago, IL, filed 2 Form D notices with the SEC between 2018 and 2025. The latest, on January 6, 2025, reports $5.2 million sold of a $8 million offering to 13 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
320 N. SANGAMON STREET, 7TH FLOOR, Chicago, IL, 60607
Phone
(872) 365-3112
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1759213

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 6, 2025New notice$8,000,000$5,246,777$2,753,22313Dec 20, 2024sec.gov
Nov 20, 2018New notice$1,300,000$900,000$400,0003Nov 1, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Lucy CoassinDirector
Vikram ChaudheryDirector
Ronnie AndrewsDirector
William HyunDirector
Joseph PetersonExecutive Officer, Director
Stacey StevensExecutive Officer, Director

Other biotechnology companies in Illinois that filed recently

Every Form D from the week of Jan 6, 2025 · All recent filings in Illinois · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what SimBioSys, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.